Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction

American Journal of Cardiology

Volumn 85, Issue 1, 2000, Pages 13-18

  Brodie, Bruce R ^a,b   Stuckey, Thomas D ^a,b   Hansen, Charles ^a   Muncy, Denise ^a,b  

^a MOSES H CONE MEMORIAL HOSPITAL   (United States)

^b LeBauer Cardiovascular Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPERFUSION; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEPARIN; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; SHOCK, CARDIOGENIC; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033956842     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00598-6     Document Type: Article

References (27)

1. Topol E.J., Califf R.M., George B.S., Kereiakes D.J., Abbottsmith C.W., Candela R.J., Lee K.L., Pitt B., Stack R.S., O'Neill W.W. A randomized trial of immediate vs. delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 317:1987;581-588.
2. Simoons M.L., Betriua A., Col J., Von Essen R., Lubsen J., Michel P.L., Rutsch W., Schmidt W., Thery C., Vahanian A., Willems G.M., Arnold A.E.R., De Bono D.P., Dougherty S.C., Lambertz H., Meier B., Raynaud P., Sanz G.A., Serruys P.W., Uebis R., Van de Werf F., Wood D. Thrombolysis with tissue plasminogen activator in acute myocardial infarction no additional benefits from immediate percutaneous coronary angioplasty . Lancet. 1:1988;197-202.
3. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction results of the thrombolysis in myocardial infarction (TIMI) Phase II Trial . N Engl J Med. 320:1989;618-627.
4. O'Neill W.W., Weintraub R., Grines C.L., Meany B., Brodie B.R., Friedman H.Z., Ramos R.G., Gangadharan V., Levin R.N., Choksi N., Westveer D.C., Strzelecki M., Timmis G.C. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty vs. lone angioplasty therapy of acute myocardial infarction. Circulation. 86:1992;1710-1717.
5. Antman E.M., Giugliano R.P., McCabe C.H., Gibson M., Adgey A.J.J., Ghali M., Coussement P., Anderson K.M., Scherer J., Van de Werf F. Braunwald E. Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trial (abstr). J Am Coll Cardiol. 319:(suppl A):1998;191A.
6. Ohman E.M., Lincoff M., Bode C., Bachinsky W.B., Ardissino D., Betriu A., Schildcrot J.S., Oliverio R., Barnathan E., Scherer J., Sketch M.S. Jr, Topol E.J. Enhanced early reperfusion at 60 minutes with low dose reteplase combined with full-dose abciximab in acute myocardial infarction preliminary results from the GUSTO-4 pilot (SPEED) dose-ranging trial . (abstr) Circulation. (suppl I):1998;I-504.
7. The use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
8. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696.
9. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet. 352:1998;87-92.
10. Brener S.J., Barr L.A., Burchenal J.E.B., Katz S., George B.S., Jones A.A., Cohen E.D., Gainey P.C., White H.J., et al. Randomized placebo- controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 98:1998;734-741.
11. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave infarction. N Engl J Med. 338:1998;1488-1497.
12. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 339:1998;436-443.
13. Brodie B.R., Weintraub R.A., Stuckey T.D., LeBauer E.J., Katz J.D., Kelly T.A., Hansen C.J. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol. 67:1991;7-12.
14. Brodie B.R. Primary angioplasty in a community hospital in the USA insights into the advantages and limitations . Br Heart J. 73:1995;411-412.
15. Brodie B.R., Grines C.L., Ivanhoe R., Knopf W., Taylor G., O'Keefe J., Weintraub R.A., Berdan L.G., Tcheng J.E., Woodlief L.H., Califf R.M., O'Neill W.W. Six month clinical and angiographic follow- up after direct angioplasty for acute myocardial infarction final results from the primary angioplasty registry . Circulation. 25:1994;155-162.
16. Stone G.W., Marsalese D., Brodie B.R., Griffin J.J., Donohue B., Costantini C., Balestrini C., Wharton T., Esente P., Spain M., et al. A prospective randomized evaluation of prophylactic intra-aortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 29:1997;1459-1467.
17. Stone G.W., Brodie B.R., Griffin J.J., Claude Morice M., Costantini C., St Goar F.G., Overlie P.A., Popma J.J., McDonnell J., Jones D., O'Neill W.W., Grines C.L. Prospective multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction in hospital and 30 day results of the PAMI stent pilot trial . J Am Coll Cardiol. 31:1998;23-30.
18. The thrombolysis in myocardial infarctions (TIMI) trial phase 1 findings . N Engl J Med. 312:1985;932-936.
19. Kennedy J.W., Trenholme S.E., Kasser I.S. Left ventricular volume and mass from single plane cineangiogram a comparison of anteroposterior and right anterior oblique methods . Am Heart J. 80:1970;343-353.
20. Gustafson J.G., Cox D., Garcia E., Mattos L., Marsalese D., Griffin J., Madonna O., Graham M., Boura J.A., Eijgelshoven M., Grines L.L., O'Neill W.W. Spontaneous patency in the early hours of AMI incidence, predictors and prognostic implications . (abstr) Circulation. 98:(suppl I):1998;I-22.
21. Lundergan C.S., Reiner J.S., Coyne K.S., Fink C., Frey A.J., Racine N., Ross A.M. Effect of delay of successful reperfusion on ventricular function outcome the case for prior thrombolytic therapy with PTCA and acute myocardial infarction . (abstr) Circulation. 98:(suppl I):1998;I-281.
22. Leiboff R.H., Katz R.J., Wasserman A.D., Bren G.B., Schwartz H., Varghese P.J., Ross A.M. A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol. 53:1984;404-407.
23. Rogers W.J., Hood W.P., Mantle J.A., Baxley W.A., Kirklin J.K., Zorn G.L., Nath H.P. Return of left ventricular function after reperfusion in patients with myocardial infarction importance of subtotal stenoses or intact collaterals . Circulation. 69:1984;338-349.
24. Brodie B.R., Weintraub R.A., Hansen C.J., Miller P.F., LeBauer E.J., Katz J.D., Stuckey T.D. Factors that predict improvement in left ventricular ejection fraction after coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn. 13:1987;372-380.
25. Rapold J.H. Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation. Lancet. 1:1990;481-482.
26. Eisenberg P.R., Sobel B.E., Jasse A.S. Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol. 19:1992;1065-1069.
27. Coller B.S. Platelet activation and thrombolytic therapy. N Engl J Med. 322:1990;33-42.